About
Cartography Biosciences is a science pipeline platform company developing cancer immunotherapies. They identify and profile antigens at unprecedented scale using single-cell genomics and proteomics to create a comprehensive antigen atlas, enabling the discovery of safer and more effective drug targets. This approach aims to widen the world of treatable cancers by creating precise, broad, and safe therapeutics for patients.
Tags
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Cartography Biosciences do?
Cartography Biosciences is a science pipeline platform company developing cancer immunotherapies. They identify and profile antigens at unprecedented scale using single-cell genomics and proteomics to create a comprehensive antigen atlas, enabling the discovery of safer and more effective drug targets. This approach aims to widen the world of treatable cancers by creating precise, broad, and safe therapeutics for patients.
How much funding has Cartography Biosciences raised?
Cartography Biosciences has raised a total of $150M in funding. The most recent round on record is Strategic Investment.
Where is Cartography Biosciences headquartered?
Cartography Biosciences is headquartered in South San Francisco, California, USA.
When was Cartography Biosciences founded?
Cartography Biosciences was founded in 2021.
What industry does Cartography Biosciences operate in?
Cartography Biosciences operates in Biotechnology, Oncology, Drug Discovery, Pharmaceuticals, Biotech, HealthTech.
Similar Startups